{"disease":{"id":"follicular-and-agressive-dlbcl-mcl-b-cell-lymphoma-patients-phase-ii","name":"follicular and agressive dlbcl mcl b cell lymphoma patients phase ii"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01582776","title":"Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell Lymphoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":317,"lead_sponsor_name":"The Lymphoma Academic Research Organisation","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}